Loading…
Serum levels of BMP-2, 4, 7 and AHSG in patients with degenerative joint disease requiring total arthroplasty of the hip and temporomandibular joints
To date, there is no objective or reliable means of assessing the severity of degenerative joint disease (DJD) and need for joint replacement surgery. Hence, it is difficult to know when an individual with DJD has reached a point where total arthroplasty is indicated. The purpose of the present stud...
Saved in:
| Published in: | Journal of orthopaedic research 2013-01, Vol.31 (1), p.44-52 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c3982-f69aa21a72d02cbac091e85f0737c3c2d884a6c25c8c9b8a79f09fced6b1edeb3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c3982-f69aa21a72d02cbac091e85f0737c3c2d884a6c25c8c9b8a79f09fced6b1edeb3 |
| container_end_page | 52 |
| container_issue | 1 |
| container_start_page | 44 |
| container_title | Journal of orthopaedic research |
| container_volume | 31 |
| creator | Albilia, Jonathan B. Tenenbaum, Howard C. Clokie, Cameron M. L. Walt, David R. Baker, Gerald I. Psutka, David J. Backstein, David Peel, Sean A. F. |
| description | To date, there is no objective or reliable means of assessing the severity of degenerative joint disease (DJD) and need for joint replacement surgery. Hence, it is difficult to know when an individual with DJD has reached a point where total arthroplasty is indicated. The purpose of the present study is to determine whether serum levels of Alpha‐2 HS‐glycoprotein (AHSG) as well as bone morphogenetic proteins (BMP‐2, 4, 7) can be used to predict the presence of severe DJD of the hip and/or temporomandibular joint (TMJ) (specifically: joints that require replacement). A total of 30 patients scheduled for arthroplasty (diseased) (15 HIP, 15 TMJ) and 120 age‐matched controls (healthy/non‐diseased) were included. Blood samples were collected from all patients ≥8 weeks after the last arthroplasty. Concentrations of serum analytes were measured using enzyme‐linked immunosorbent assays, and these were compared between the Diseased and Healthy groups, utilizing the Mann–Whitney U‐test. Patients with disease had significantly higher levels of BMP‐2 and BMP‐4 and lower levels of AHSG in serum compared to non‐diseased humans (p |
| doi_str_mv | 10.1002/jor.22182 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1220365175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1220365175</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3982-f69aa21a72d02cbac091e85f0737c3c2d884a6c25c8c9b8a79f09fced6b1edeb3</originalsourceid><addsrcrecordid>eNp1kc9O3DAQh62qVdnSHvoClY9FImA7G9s5AioLFS0I6J-b5TgT1lsnDrYD7IPwvgQC3HryyPrmG838EPpMyQ4lhO2ufNhhjEr2Bs1oUcyzgom_b9GMiJxnhHG-gT7EuCKECMrke7TBmBCSFOUM3V9AGFrs4AZcxL7B-z_OMraN59tYYN3VeO_oYoFth3udLHQp4lublriGK-ggjH83gFfedgnXNoKOgANcDzbY7gonn7TDOqRl8L3TMa0fB6Ql4KXtn-QJ2t4H3461rQanw-SKH9G7RrsIn57fTfTr8NvlwVF2cro4Ptg7yUxeSpY1vNSaUS1YTZiptCElBVk0497C5IbVUs41N6ww0pSV1KJsSNkYqHlFoYYq30RfJ28f_PUAManWRgPO6Q78EBVljOS8oKIY0a0JNcHHGKBRfbCtDmtFiXpMQY0pqKcURvbLs3aoWqhfyZezj8DuBNxaB-v_m9T30_MXZTZ12Jjg7rVDh3-Kj9sW6s_PhZpT_nuxf0bVYf4AX-miVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1220365175</pqid></control><display><type>article</type><title>Serum levels of BMP-2, 4, 7 and AHSG in patients with degenerative joint disease requiring total arthroplasty of the hip and temporomandibular joints</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Albilia, Jonathan B. ; Tenenbaum, Howard C. ; Clokie, Cameron M. L. ; Walt, David R. ; Baker, Gerald I. ; Psutka, David J. ; Backstein, David ; Peel, Sean A. F.</creator><creatorcontrib>Albilia, Jonathan B. ; Tenenbaum, Howard C. ; Clokie, Cameron M. L. ; Walt, David R. ; Baker, Gerald I. ; Psutka, David J. ; Backstein, David ; Peel, Sean A. F.</creatorcontrib><description>To date, there is no objective or reliable means of assessing the severity of degenerative joint disease (DJD) and need for joint replacement surgery. Hence, it is difficult to know when an individual with DJD has reached a point where total arthroplasty is indicated. The purpose of the present study is to determine whether serum levels of Alpha‐2 HS‐glycoprotein (AHSG) as well as bone morphogenetic proteins (BMP‐2, 4, 7) can be used to predict the presence of severe DJD of the hip and/or temporomandibular joint (TMJ) (specifically: joints that require replacement). A total of 30 patients scheduled for arthroplasty (diseased) (15 HIP, 15 TMJ) and 120 age‐matched controls (healthy/non‐diseased) were included. Blood samples were collected from all patients ≥8 weeks after the last arthroplasty. Concentrations of serum analytes were measured using enzyme‐linked immunosorbent assays, and these were compared between the Diseased and Healthy groups, utilizing the Mann–Whitney U‐test. Patients with disease had significantly higher levels of BMP‐2 and BMP‐4 and lower levels of AHSG in serum compared to non‐diseased humans (p < 0.01). Higher levels of BMP‐2, 4 and reduced levels of AHSG appear to characterize patients who have DJD that is severe enough to require total joint replacement. Perhaps measurements of these proteins can be used to make objective decisions regarding the need for total arthroplasty as opposed to the current subjective approaches. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31:44–52, 2012</description><identifier>ISSN: 0736-0266</identifier><identifier>EISSN: 1554-527X</identifier><identifier>DOI: 10.1002/jor.22182</identifier><identifier>PMID: 22778059</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Aged, 80 and over ; AHSG/Fetuin ; alpha-2-HS-Glycoprotein - metabolism ; arthritis ; Arthroplasty, Replacement ; Arthroplasty, Replacement, Hip ; Biomarkers - blood ; BMP ; Bone Morphogenetic Protein 2 - blood ; Bone Morphogenetic Protein 4 - blood ; Bone Morphogenetic Protein 7 - blood ; Bone Morphogenetic Proteins - blood ; Female ; hip ; Humans ; Male ; Middle Aged ; Osteoarthritis, Hip - blood ; Osteoarthritis, Hip - diagnosis ; Osteoarthritis, Hip - surgery ; Predictive Value of Tests ; Preoperative Care - methods ; Severity of Illness Index ; Temporomandibular Joint Disorders - blood ; Temporomandibular Joint Disorders - diagnosis ; Temporomandibular Joint Disorders - surgery ; TMJ ; Young Adult</subject><ispartof>Journal of orthopaedic research, 2013-01, Vol.31 (1), p.44-52</ispartof><rights>Copyright © 2012 Orthopaedic Research Society</rights><rights>Copyright © 2012 Orthopaedic Research Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3982-f69aa21a72d02cbac091e85f0737c3c2d884a6c25c8c9b8a79f09fced6b1edeb3</citedby><cites>FETCH-LOGICAL-c3982-f69aa21a72d02cbac091e85f0737c3c2d884a6c25c8c9b8a79f09fced6b1edeb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22778059$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Albilia, Jonathan B.</creatorcontrib><creatorcontrib>Tenenbaum, Howard C.</creatorcontrib><creatorcontrib>Clokie, Cameron M. L.</creatorcontrib><creatorcontrib>Walt, David R.</creatorcontrib><creatorcontrib>Baker, Gerald I.</creatorcontrib><creatorcontrib>Psutka, David J.</creatorcontrib><creatorcontrib>Backstein, David</creatorcontrib><creatorcontrib>Peel, Sean A. F.</creatorcontrib><title>Serum levels of BMP-2, 4, 7 and AHSG in patients with degenerative joint disease requiring total arthroplasty of the hip and temporomandibular joints</title><title>Journal of orthopaedic research</title><addtitle>J. Orthop. Res</addtitle><description>To date, there is no objective or reliable means of assessing the severity of degenerative joint disease (DJD) and need for joint replacement surgery. Hence, it is difficult to know when an individual with DJD has reached a point where total arthroplasty is indicated. The purpose of the present study is to determine whether serum levels of Alpha‐2 HS‐glycoprotein (AHSG) as well as bone morphogenetic proteins (BMP‐2, 4, 7) can be used to predict the presence of severe DJD of the hip and/or temporomandibular joint (TMJ) (specifically: joints that require replacement). A total of 30 patients scheduled for arthroplasty (diseased) (15 HIP, 15 TMJ) and 120 age‐matched controls (healthy/non‐diseased) were included. Blood samples were collected from all patients ≥8 weeks after the last arthroplasty. Concentrations of serum analytes were measured using enzyme‐linked immunosorbent assays, and these were compared between the Diseased and Healthy groups, utilizing the Mann–Whitney U‐test. Patients with disease had significantly higher levels of BMP‐2 and BMP‐4 and lower levels of AHSG in serum compared to non‐diseased humans (p < 0.01). Higher levels of BMP‐2, 4 and reduced levels of AHSG appear to characterize patients who have DJD that is severe enough to require total joint replacement. Perhaps measurements of these proteins can be used to make objective decisions regarding the need for total arthroplasty as opposed to the current subjective approaches. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31:44–52, 2012</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>AHSG/Fetuin</subject><subject>alpha-2-HS-Glycoprotein - metabolism</subject><subject>arthritis</subject><subject>Arthroplasty, Replacement</subject><subject>Arthroplasty, Replacement, Hip</subject><subject>Biomarkers - blood</subject><subject>BMP</subject><subject>Bone Morphogenetic Protein 2 - blood</subject><subject>Bone Morphogenetic Protein 4 - blood</subject><subject>Bone Morphogenetic Protein 7 - blood</subject><subject>Bone Morphogenetic Proteins - blood</subject><subject>Female</subject><subject>hip</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Osteoarthritis, Hip - blood</subject><subject>Osteoarthritis, Hip - diagnosis</subject><subject>Osteoarthritis, Hip - surgery</subject><subject>Predictive Value of Tests</subject><subject>Preoperative Care - methods</subject><subject>Severity of Illness Index</subject><subject>Temporomandibular Joint Disorders - blood</subject><subject>Temporomandibular Joint Disorders - diagnosis</subject><subject>Temporomandibular Joint Disorders - surgery</subject><subject>TMJ</subject><subject>Young Adult</subject><issn>0736-0266</issn><issn>1554-527X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp1kc9O3DAQh62qVdnSHvoClY9FImA7G9s5AioLFS0I6J-b5TgT1lsnDrYD7IPwvgQC3HryyPrmG838EPpMyQ4lhO2ufNhhjEr2Bs1oUcyzgom_b9GMiJxnhHG-gT7EuCKECMrke7TBmBCSFOUM3V9AGFrs4AZcxL7B-z_OMraN59tYYN3VeO_oYoFth3udLHQp4lublriGK-ggjH83gFfedgnXNoKOgANcDzbY7gonn7TDOqRl8L3TMa0fB6Ql4KXtn-QJ2t4H3461rQanw-SKH9G7RrsIn57fTfTr8NvlwVF2cro4Ptg7yUxeSpY1vNSaUS1YTZiptCElBVk0497C5IbVUs41N6ww0pSV1KJsSNkYqHlFoYYq30RfJ28f_PUAManWRgPO6Q78EBVljOS8oKIY0a0JNcHHGKBRfbCtDmtFiXpMQY0pqKcURvbLs3aoWqhfyZezj8DuBNxaB-v_m9T30_MXZTZ12Jjg7rVDh3-Kj9sW6s_PhZpT_nuxf0bVYf4AX-miVg</recordid><startdate>201301</startdate><enddate>201301</enddate><creator>Albilia, Jonathan B.</creator><creator>Tenenbaum, Howard C.</creator><creator>Clokie, Cameron M. L.</creator><creator>Walt, David R.</creator><creator>Baker, Gerald I.</creator><creator>Psutka, David J.</creator><creator>Backstein, David</creator><creator>Peel, Sean A. F.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201301</creationdate><title>Serum levels of BMP-2, 4, 7 and AHSG in patients with degenerative joint disease requiring total arthroplasty of the hip and temporomandibular joints</title><author>Albilia, Jonathan B. ; Tenenbaum, Howard C. ; Clokie, Cameron M. L. ; Walt, David R. ; Baker, Gerald I. ; Psutka, David J. ; Backstein, David ; Peel, Sean A. F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3982-f69aa21a72d02cbac091e85f0737c3c2d884a6c25c8c9b8a79f09fced6b1edeb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>AHSG/Fetuin</topic><topic>alpha-2-HS-Glycoprotein - metabolism</topic><topic>arthritis</topic><topic>Arthroplasty, Replacement</topic><topic>Arthroplasty, Replacement, Hip</topic><topic>Biomarkers - blood</topic><topic>BMP</topic><topic>Bone Morphogenetic Protein 2 - blood</topic><topic>Bone Morphogenetic Protein 4 - blood</topic><topic>Bone Morphogenetic Protein 7 - blood</topic><topic>Bone Morphogenetic Proteins - blood</topic><topic>Female</topic><topic>hip</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Osteoarthritis, Hip - blood</topic><topic>Osteoarthritis, Hip - diagnosis</topic><topic>Osteoarthritis, Hip - surgery</topic><topic>Predictive Value of Tests</topic><topic>Preoperative Care - methods</topic><topic>Severity of Illness Index</topic><topic>Temporomandibular Joint Disorders - blood</topic><topic>Temporomandibular Joint Disorders - diagnosis</topic><topic>Temporomandibular Joint Disorders - surgery</topic><topic>TMJ</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Albilia, Jonathan B.</creatorcontrib><creatorcontrib>Tenenbaum, Howard C.</creatorcontrib><creatorcontrib>Clokie, Cameron M. L.</creatorcontrib><creatorcontrib>Walt, David R.</creatorcontrib><creatorcontrib>Baker, Gerald I.</creatorcontrib><creatorcontrib>Psutka, David J.</creatorcontrib><creatorcontrib>Backstein, David</creatorcontrib><creatorcontrib>Peel, Sean A. F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of orthopaedic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Albilia, Jonathan B.</au><au>Tenenbaum, Howard C.</au><au>Clokie, Cameron M. L.</au><au>Walt, David R.</au><au>Baker, Gerald I.</au><au>Psutka, David J.</au><au>Backstein, David</au><au>Peel, Sean A. F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum levels of BMP-2, 4, 7 and AHSG in patients with degenerative joint disease requiring total arthroplasty of the hip and temporomandibular joints</atitle><jtitle>Journal of orthopaedic research</jtitle><addtitle>J. Orthop. Res</addtitle><date>2013-01</date><risdate>2013</risdate><volume>31</volume><issue>1</issue><spage>44</spage><epage>52</epage><pages>44-52</pages><issn>0736-0266</issn><eissn>1554-527X</eissn><abstract>To date, there is no objective or reliable means of assessing the severity of degenerative joint disease (DJD) and need for joint replacement surgery. Hence, it is difficult to know when an individual with DJD has reached a point where total arthroplasty is indicated. The purpose of the present study is to determine whether serum levels of Alpha‐2 HS‐glycoprotein (AHSG) as well as bone morphogenetic proteins (BMP‐2, 4, 7) can be used to predict the presence of severe DJD of the hip and/or temporomandibular joint (TMJ) (specifically: joints that require replacement). A total of 30 patients scheduled for arthroplasty (diseased) (15 HIP, 15 TMJ) and 120 age‐matched controls (healthy/non‐diseased) were included. Blood samples were collected from all patients ≥8 weeks after the last arthroplasty. Concentrations of serum analytes were measured using enzyme‐linked immunosorbent assays, and these were compared between the Diseased and Healthy groups, utilizing the Mann–Whitney U‐test. Patients with disease had significantly higher levels of BMP‐2 and BMP‐4 and lower levels of AHSG in serum compared to non‐diseased humans (p < 0.01). Higher levels of BMP‐2, 4 and reduced levels of AHSG appear to characterize patients who have DJD that is severe enough to require total joint replacement. Perhaps measurements of these proteins can be used to make objective decisions regarding the need for total arthroplasty as opposed to the current subjective approaches. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31:44–52, 2012</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>22778059</pmid><doi>10.1002/jor.22182</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0736-0266 |
| ispartof | Journal of orthopaedic research, 2013-01, Vol.31 (1), p.44-52 |
| issn | 0736-0266 1554-527X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1220365175 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | Adult Aged Aged, 80 and over AHSG/Fetuin alpha-2-HS-Glycoprotein - metabolism arthritis Arthroplasty, Replacement Arthroplasty, Replacement, Hip Biomarkers - blood BMP Bone Morphogenetic Protein 2 - blood Bone Morphogenetic Protein 4 - blood Bone Morphogenetic Protein 7 - blood Bone Morphogenetic Proteins - blood Female hip Humans Male Middle Aged Osteoarthritis, Hip - blood Osteoarthritis, Hip - diagnosis Osteoarthritis, Hip - surgery Predictive Value of Tests Preoperative Care - methods Severity of Illness Index Temporomandibular Joint Disorders - blood Temporomandibular Joint Disorders - diagnosis Temporomandibular Joint Disorders - surgery TMJ Young Adult |
| title | Serum levels of BMP-2, 4, 7 and AHSG in patients with degenerative joint disease requiring total arthroplasty of the hip and temporomandibular joints |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T22%3A47%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20levels%20of%20BMP-2,%204,%207%20and%20AHSG%20in%20patients%20with%20degenerative%20joint%20disease%20requiring%20total%20arthroplasty%20of%20the%20hip%20and%20temporomandibular%20joints&rft.jtitle=Journal%20of%20orthopaedic%20research&rft.au=Albilia,%20Jonathan%20B.&rft.date=2013-01&rft.volume=31&rft.issue=1&rft.spage=44&rft.epage=52&rft.pages=44-52&rft.issn=0736-0266&rft.eissn=1554-527X&rft_id=info:doi/10.1002/jor.22182&rft_dat=%3Cproquest_cross%3E1220365175%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3982-f69aa21a72d02cbac091e85f0737c3c2d884a6c25c8c9b8a79f09fced6b1edeb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1220365175&rft_id=info:pmid/22778059&rfr_iscdi=true |